264 related articles for article (PubMed ID: 16014636)
21. Constipation, polyps, or cancer? Let PTEN predict your future.
Eng C
Am J Med Genet A; 2003 Nov; 122A(4):315-22. PubMed ID: 14518069
[TBL] [Abstract][Full Text] [Related]
22. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.
Waite KA; Eng C
Hum Mol Genet; 2003 Mar; 12(6):679-84. PubMed ID: 12620973
[TBL] [Abstract][Full Text] [Related]
23. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
Ge NL; Rudikoff S
Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
[TBL] [Abstract][Full Text] [Related]
24. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
25. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
[TBL] [Abstract][Full Text] [Related]
26. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
[TBL] [Abstract][Full Text] [Related]
27. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
Eng C
Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
[TBL] [Abstract][Full Text] [Related]
28. Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
Shi W; Zhang X; Pintilie M; Ma N; Miller N; Banerjee D; Tsao MS; Mak T; Fyles A; Liu FF
Int J Cancer; 2003 Mar; 104(2):195-203. PubMed ID: 12569575
[TBL] [Abstract][Full Text] [Related]
29. Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population.
Ishihara H; Sasaoka T; Kagawa S; Murakami S; Fukui K; Kawagishi Y; Yamazaki K; Sato A; Iwata M; Urakaze M; Ishiki M; Wada T; Yaguchi S; Tsuneki H; Kimura I; Kobayashi M
FEBS Lett; 2003 Nov; 554(3):450-4. PubMed ID: 14623110
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the human PTEN gene.
Bonneau D; Longy M
Hum Mutat; 2000; 16(2):109-22. PubMed ID: 10923032
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome.
Pezzolesi MG; Zbuk KM; Waite KA; Eng C
Hum Mol Genet; 2007 May; 16(9):1058-71. PubMed ID: 17341483
[TBL] [Abstract][Full Text] [Related]
32. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
33. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome.
Carethers JM; Furnari FB; Zigman AF; Lavine JE; Jones MC; Graham GE; Teebi AS; Huang HJ; Ha HT; Chauhan DP; Chang CL; Cavenee WK; Boland CR
Cancer Res; 1998 Jul; 58(13):2724-6. PubMed ID: 9661881
[TBL] [Abstract][Full Text] [Related]
34. Genetic heterogeneity in familial juvenile polyposis.
Huang SC; Chen CR; Lavine JE; Taylor SF; Newbury RO; Pham TT; Ricciardiello L; Carethers JM
Cancer Res; 2000 Dec; 60(24):6882-5. PubMed ID: 11156385
[TBL] [Abstract][Full Text] [Related]
35. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
Zori RT; Marsh DJ; Graham GE; Marliss EB; Eng C
Am J Med Genet; 1998 Dec; 80(4):399-402. PubMed ID: 9856571
[TBL] [Abstract][Full Text] [Related]
36. Protean PTEN: form and function.
Waite KA; Eng C
Am J Hum Genet; 2002 Apr; 70(4):829-44. PubMed ID: 11875759
[TBL] [Abstract][Full Text] [Related]
37. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
38. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
39. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
40. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
